Medical Alley, Minn. — Altheia, Inc., a leading innovator in the field of predictive healthcare analytics, is pleased to announce the company has been approved for Minnesota’s Angel Tax Credit for the remainder of 2023. This designation signifies a significant milestone in Altheia’s journey, reinforcing the company’s potential and making it an attractive opportunity for angel investors.
“We are honored to be approved for Minnesota’s Angel Tax Credit, an initiative which highlights and supports cutting-edge firms in the technology space,” Altheia Founder and CEO Jolly Nanda said. “This recognition validates the pioneering work we’re doing to revolutionize predictive healthcare through analytics. We are thrilled to open new opportunities for investors who share our mission to leverage AI and big data to improve health outcomes.”
Altheia, Inc. utilizes artificial intelligence and machine learning technologies to predict potential health risks and diseases before they present, providing intelligent prioritization for case managers and empowering people to take proactive measures to maintain their health. The company’s Predictive Healthcare Platform analyzes a broad range of risk factors to deliver the targeted segmentation needed to predict, identify, and provide early treatment for today’s costliest chronic conditions – including chronic kidney disease, cardiovascular disease, diabetes, hypertension, and COPD.
Minnesota’s Angel Tax Credit provides a compelling incentive for investors, minimizing risk while supporting companies that are on the leading edge of innovation. The program provides a 25% tax credit to investors or investment funds which make equity investments in startup companies focused on high technology, new proprietary technology, or a new proprietary product, process, or service. Investment is available to qualified individuals or companies located anywhere in the world.
Since 2010, more than $500 million has been invested in Minnesota companies via the state’s Angel Tax Credit — resulting in the creation of more than 2,200 new jobs.
About Altheia, Inc.
Altheia, Inc. is an innovative early-stage B2B SaaS company operating in the Healthcare Technology and Care Management industry. Our goal is to empower chronic care management companies to significantly improve patient outcomes while reducing operating costs and increasing profitability. We offer a predictive analytics platform that revolutionizes disease management and patient wellness. By utilizing our proprietary rules-based analytics engine, we generate more reliable predictions and enable earlier disease identification and treatment.
